l9n/ Oregon

2007 Regular Session

House Bill 2523

Requires pharmaceutical manufacturing companies to annually disclose to Department of Justice certain economic benefits provided in conjunction with marketing of prescription drugs.

Did not become law. It stopped in the House of Representatives's Health Care Committee on June 28, 2007. The 2007 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Requires pharmaceutical manufacturing companies to annually disclose to Department of Justice certain economic benefits provided in conjunction with marketing of prescription drugs. Directs department to report disclosures to Legislative Assembly and Governor. Authorizes imposition of civil penalty, not to exceed $10,000 for each violation, for failure to disclose required information. Establishes Pharmaceutical Marketing Disclosure Fund. Appropriates moneys in fund to department for administration of Act. Declares emergency, effective on passage.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

21 co-sponsors

Jeff Barker, Phil Barnhart, Suzanne Bonamici, Deborah Boone, Peter Buckley, Ben Cannon, Brian Clem, Jean Cowan, Jackie Dingfelder, Chris Edwards, Larry Galizio, Sara Gelser Blouin, Paul Holvey, Betty Komp, Donna Nelson, Mary Nolan, Chuck Riley, Diane Rosenbaum, Chip Shields, Brad Witt, Nancy Nathanson

Its course

January 30 to June 28, 2007, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action4 actions on 4 days

In the House of RepresentativesJan 30 to Jun 28 · stopped149 days

Waiting for a committeeJan 30 to Feb 67 days

Health CareFeb 6 to Jun 28 · stopped142 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Jan 30 – Jun 28

  1. Jan 30Introduced
  2. Feb 6Sent to Health Care
  3. Feb 16Heard in Health Care
  4. Jun 28Died when the session ended
All 4 actions, as published
  1. Jan 30First reading. Referred to Speaker's desk.House of Representatives
  2. Feb 6Referred to Health Care with subsequent referral to Ways and Means.House of Representatives
  3. Feb 16Public Hearing held.House of Representatives
  4. Jun 28In committee upon adjournment.House of Representatives